Cite
HARVARD Citation
Boull, C. et al. (n.d.). Cutaneous Reactions in Children Treated with the Mitogen‐Activated Protein Kinase Extracellular Signal‐Regulated Kinase Inhibitor Trametinib for Neural Tumors. Pediatric dermatology. 34 (1), pp. 90-94. [Online].